Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sunnybrook Health Sciences Centre
With
Canadian Association of Radiation Oncology
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Men \>18 years
Histologically confirmed prostate adenocarcinoma
Low or low-intermediate risk prostate cancer, defined as Clinical stage T1-2b, Gleason Score \<=6, and PSA \<15 ng/mL, OR Clinical stage T1-2b, Gleason Score 7, and PSA \<=10 ng/mL
You may not be if
Prior pelvic radiotherapy
Anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Diagnosis of bleeding diathesis
Presence of a hip prosthesis
Pelvic girth \>40cm - Large prostate (\>90cm3) on imaging
Severe lower urinary tract symptoms (International Prostate Symptom Score \>19 or nocturia \>3)
